New Key Statistics Module, Z-Score and F-Score
NAS:BBIO Key Ratios
| Market Cap $ M | 4,563.35 |
| Enterprise Value $ M | 5,911.65 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 444.46 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 9.00 |
| EPS (TTM) $ | -3.94 |
| Beneish M-Score | -5.66 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -9.70 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -10.36 |
| EV-to-EBITDA | -10.47 |
| PEG | -- |
| Shares Outstanding M | 184.45 |
| Net Margin (%) | -6,913.92 |
| Operating Margin % | -6,443.56 |
| Pre-tax Margin (%) | -7,021.94 |
| Quick Ratio | 3.32 |
| Current Ratio | 3.32 |
| ROA % (ttm) | -108.88 |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -519.36 |
| Dividend Yield % | -- |
| Altman Z-Score | -7.80 |
| Piotroski F-Score | 1.00 |
| Positive ROA | N |
| Positive CFROA | N |
| Higher ROA y-y | N |
| Cash flow > Earnings | Y |
| Lower Leverage y-y | N |
| Higher Current Ratio y-y | N |
| Less Shares Outstanding y-y | N |
| Gross Margin Increase y-y | N |
| Higher Asset Turnover y-y | N |
BBIO Number of Guru Trades
BBIO Volume of Guru Trades
Gurus Latest Trades with NAS:BBIO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:BBIO is held by these investors
Total 2
BridgeBio Pharma Inc Insider Transactions
No Available Data
News about NAS:BBIO
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers